Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer managementYuma Goto, Yuya Iwamoto, Keiichiro Miyajima et al.|British Journal of Urology|2025Cited by 4
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort studyKosuke Iwatani, Takahiro Kimura, Fumihiko Urabe et al.|Japanese Journal of Clinical Oncology|2025Cited by 4
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative studyFumihiko Urabe, Soshi Kadena, Kojiro Tashiro et al.|Japanese Journal of Clinical Oncology|2025Cited by 3
Apalutamide-induced rash and relative dose intensity in metastatic castration-sensitive prostate cancer: a multicenter Japanese cohort studyFumihiko Urabe, Takahiro Kimura, Hajime Onuma et al.|Translational Andrology and Urology|2025Cited by 2